Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Beyond the visual T2-FLAIR mismatch: quantitative imaging markers of IDH mutation in Gliomas-A retrospective diagnostic accuracy study.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology - 11 Sept 2026

Bilgin Ezel Yaltırık, Ünal Özkan, Alkan Banu İnce

Abstract excerpt

BACKGROUND: Accurate noninvasive prediction of isocitrate dehydrogenase (IDH) mutation status is essential for the classification, prognostication, and management of diffuse gliomas. PURPOSE: To evaluate quantitative and semi-quantitative T2-FLAIR-based MRI parameters for differentiating IDH-mutant from IDH-wildtype gliomas. METHODS: This retrospective study included 29 patients with histopathologically confirmed...

Read the complete abstract on PubMed

Topics

Humans
Glioma
Isocitrate Dehydrogenase
Brain Neoplasms
Retrospective Studies
Female

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Magnetic Resonance Imaging

Male

Mutation

Middle Aged

Adult

Aged

Source

Identifiers

PMID: 42726300
DOI: 10.1007/s10072-026-09387-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 24 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Beyond the visual T2-FLAIR mismatch: quantitative imaging markers of IDH mutation in Gliomas-A retrospective diagnostic accuracy study.PMID 42726300Read ↗

Clinicopathological and radiological characteristics of false-positive and false-negative results in T2-FLAIR mismatch sign of IDH-mutated gliomas.Semantic proximity Read ↗

Diffusion MRI is superior to quantitative T2-FLAIR mismatch in predicting molecular subtypes of human non-enhancing gliomas.Semantic proximity Read ↗

Core-based voxel-wise T2-FLAIR mismatch analysis for differentiation of IDH-mutant astrocytomas from oligodendrogliomas.Semantic proximity Read ↗

Radiogenomic association between the T2-FLAIR mismatch sign and IDH mutation status in adult patients with lower-grade gliomas: an updated systematic review and meta-analysis.Semantic proximity Read ↗

Patterns of T2-FLAIR discordance across a cohort of adult-type diffuse gliomas and deviations from the classic T2-FLAIR mismatch sign.Semantic proximity Read ↗

Identification of T2W hypointense ring as a novel noninvasive indicator for glioma grade and IDH genotype.Semantic proximity Read ↗

The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation study.Semantic proximity Read ↗

The reliability and interobserver reproducibility of T2/FLAIR mismatch in the diagnosis of IDH-mutant astrocytomas.Semantic proximity Read ↗

Association of partial T2-FLAIR mismatch sign and isocitrate dehydrogenase mutation in WHO grade 4 gliomas: results from the ReSPOND consortium.Semantic proximity Read ↗

Imaging prediction of isocitrate dehydrogenase (IDH) mutation in patients with glioma: a systemic review and meta-analysis.Semantic proximity Read ↗

Usefulness of synthetic MRI for differentiation of IDH-mutant diffuse gliomas and its comparison with the T2-FLAIR mismatch sign.Semantic proximity Read ↗

"Real world" use of a highly reliable imaging sign: "T2-FLAIR mismatch" for identification of IDH mutant astrocytomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.